Archives gilead-sciences

by in
Entry Author Date Location
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug 08/31/15 Boston
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More 07/06/15 Seattle
Failed Trial for Hepatitis B Drug Leads to Layoffs at GlobeImmune 06/10/15 Boulder/Denver
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday 05/27/15 New York
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More 05/15/15 San Diego
West Coast Biotech Roundup: Adaptive, Gilead, Juno, aTyr & More 05/08/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
With Asklepion Deal, Retrophin Gets a New Drug—And a Voucher 03/18/15 New York
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test 03/18/15 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
CTI Goes Up, And Down, And Back Up On Phase 3 Myelofibrosis News 03/09/15 Seattle
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
Chimerix Drug Shows Promise As Virus Fighter for Transplant Patients 03/02/15 Raleigh Durham
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
Hepatitis C Commercial Game Theory 01/01/15 National
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Enanta Pockets $75M As AbbVie, Gilead Hep C Battle Begins 12/19/14 Boston
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda 12/10/14 San Francisco
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
Page 1 of 8 next page »